{"id":"https://openalex.org/W7202074958","doi":"https://doi.org/10.33380/2305-2066-2026-15-3-2368","title":"Current approaches to paclitaxel formulation development: challenges and future perspectives (review)","display_name":"Current approaches to paclitaxel formulation development: challenges and future perspectives (review)","publication_year":2026,"publication_date":"2026-08-10","ids":{"openalex":"https://openalex.org/W7202074958","doi":"https://doi.org/10.33380/2305-2066-2026-15-3-2368"},"language":"en","primary_location":{"id":"doi:10.33380/2305-2066-2026-15-3-2368","doi":"https://doi.org/10.33380/2305-2066-2026-15-3-2368","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2026-15-3-2368","pdf_url":null,"source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development & registration","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.33380/2305-2066-2026-15-3-2368","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5147191030","display_name":"A. S. Barazova","orcid":"https://orcid.org/0009-0000-0535-6602","observed_orcids":["https://orcid.org/0009-0000-0535-6602"]},"institutions":[{"id":"https://openalex.org/I4405258012","display_name":"Federal State Budgetary Institution \u2018Scientific Centre for Expert Evaluation of Medicinal Products\u2019 of the Ministry of Health of the Russian Federation (SCEEMP)","ror":"https://ror.org/05xze5t06","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4405258012"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. S. Barazova","raw_affiliation_strings":["Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP)"],"raw_orcid":"https://orcid.org/0009-0000-0535-6602","affiliations":[{"raw_affiliation_string":"Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP)","institution_ids":["https://openalex.org/I4405258012"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049609250","display_name":"S. V. Ovsienko","orcid":"https://orcid.org/0000-0001-9649-716X","observed_orcids":["https://orcid.org/0000-0001-9649-716X"]},"institutions":[{"id":"https://openalex.org/I4405258012","display_name":"Federal State Budgetary Institution \u2018Scientific Centre for Expert Evaluation of Medicinal Products\u2019 of the Ministry of Health of the Russian Federation (SCEEMP)","ror":"https://ror.org/05xze5t06","country_code":"RU","type":"government","lineage":["https://openalex.org/I4210117042","https://openalex.org/I4405258012"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"S. V. Ovsienko","raw_affiliation_strings":["Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP)"],"raw_orcid":"https://orcid.org/0000-0001-9649-716X","affiliations":[{"raw_affiliation_string":"Scientific Centre for Expert Evaluation of Medicinal Products (SCEEMP)","institution_ids":["https://openalex.org/I4405258012"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054883688","display_name":"\u041d.\u0410. \u0411\u0435\u0441\u0435\u0434\u0438\u043d\u0430","orcid":"https://orcid.org/0009-0006-1762-3740","observed_orcids":["https://orcid.org/0009-0006-1762-3740"]},"institutions":[{"id":"https://openalex.org/I4210100229","display_name":"Institute of Engineering Physics","ror":"https://ror.org/0104w4x66","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100229"]},{"id":"https://openalex.org/I887846188","display_name":"National Research Nuclear University MEPhI","ror":"https://ror.org/04w8z7f34","country_code":"RU","type":"education","lineage":["https://openalex.org/I887846188"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"N. A. Besedina","raw_affiliation_strings":["National Research Nuclear University MEPhI (Moscow Engineering Physics Institute). Institute of Engineering Physics for Biomedicine"],"raw_orcid":"https://orcid.org/0009-0006-1762-3740","affiliations":[{"raw_affiliation_string":"National Research Nuclear University MEPhI (Moscow Engineering Physics Institute). Institute of Engineering Physics for Biomedicine","institution_ids":["https://openalex.org/I4210100229","https://openalex.org/I887846188"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034249553","display_name":"Alla Yu. Savchenko","orcid":"https://orcid.org/0000-0003-2734-5036","observed_orcids":["https://orcid.org/0000-0003-2734-5036"]},"institutions":[{"id":"https://openalex.org/I4210100229","display_name":"Institute of Engineering Physics","ror":"https://ror.org/0104w4x66","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100229"]},{"id":"https://openalex.org/I887846188","display_name":"National Research Nuclear University MEPhI","ror":"https://ror.org/04w8z7f34","country_code":"RU","type":"education","lineage":["https://openalex.org/I887846188"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. Yu. Savchenko","raw_affiliation_strings":["National Research Nuclear University MEPhI (Moscow Engineering Physics Institute). Institute of Engineering Physics for Biomedicine"],"raw_orcid":"https://orcid.org/0000-0003-2734-5036","affiliations":[{"raw_affiliation_string":"National Research Nuclear University MEPhI (Moscow Engineering Physics Institute). Institute of Engineering Physics for Biomedicine","institution_ids":["https://openalex.org/I4210100229","https://openalex.org/I887846188"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5133327894","display_name":"A. Ya. Khaimenov","orcid":"https://orcid.org/0009-0000-3128-8025","observed_orcids":["https://orcid.org/0009-0000-3128-8025"]},"institutions":[{"id":"https://openalex.org/I4210100229","display_name":"Institute of Engineering Physics","ror":"https://ror.org/0104w4x66","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100229"]},{"id":"https://openalex.org/I887846188","display_name":"National Research Nuclear University MEPhI","ror":"https://ror.org/04w8z7f34","country_code":"RU","type":"education","lineage":["https://openalex.org/I887846188"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. Ya. Khaymenov","raw_affiliation_strings":["National Research Nuclear University MEPhI (Moscow Engineering Physics Institute). Institute of Engineering Physics for Biomedicine"],"raw_orcid":"https://orcid.org/0009-0000-3128-8025","affiliations":[{"raw_affiliation_string":"National Research Nuclear University MEPhI (Moscow Engineering Physics Institute). Institute of Engineering Physics for Biomedicine","institution_ids":["https://openalex.org/I4210100229","https://openalex.org/I887846188"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"3","first_page":"86","last_page":"98"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.6147000193595886,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.6147000193595886,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.3433000147342682,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/pharmaceutical-formulation-development","display_name":"drug formulation development","score":0.8939999938011169},{"id":"https://openalex.org/keywords/low-water-solubility","display_name":"low water solubility","score":0.8429999947547913},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5669999718666077},{"id":"https://openalex.org/keywords/polymorphism","display_name":"polymorphism","score":0.9100000262260437},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.5609999895095825},{"id":"https://openalex.org/keywords/microtubule-stabilization","display_name":"microtubule stabilization","score":0.8840000033378601},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.6470000147819519},{"id":"https://openalex.org/keywords/restenosis","display_name":"restenosis","score":0.6140000224113464},{"id":"https://openalex.org/keywords/angioplasty","display_name":"angioplasty","score":0.5820000171661377},{"id":"https://openalex.org/keywords/dosage-forms","display_name":"pharmaceutical dosage forms","score":0.5419999957084656}],"concepts":[{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.960099995136261},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.7599999904632568},{"id":"https://openalex.org/C2781047461","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutical","level":2,"score":0.6456000208854675},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5899999737739563},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5820000171661377},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.5008999705314636},{"id":"https://openalex.org/C188198153","wikidata":"https://www.wikidata.org/wiki/Q1613840","display_name":"Limiting","level":2,"score":0.41190001368522644},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.400299996137619},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.29760000109672546},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.29429998993873596},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.28690001368522644},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.27379998564720154},{"id":"https://openalex.org/C19831878","wikidata":"https://www.wikidata.org/wiki/Q659446","display_name":"Therapeutic index","level":3,"score":0.25940001010894775},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.25760000944137573}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.33380/2305-2066-2026-15-3-2368","doi":"https://doi.org/10.33380/2305-2066-2026-15-3-2368","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2026-15-3-2368","pdf_url":null,"source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development & registration","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.33380/2305-2066-2026-15-3-2368","doi":"https://doi.org/10.33380/2305-2066-2026-15-3-2368","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2026-15-3-2368","pdf_url":null,"source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development & registration","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8048999905586243,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":57,"referenced_works":["https://openalex.org/W1550820777","https://openalex.org/W1966858550","https://openalex.org/W1974189322","https://openalex.org/W1976423399","https://openalex.org/W1984820569","https://openalex.org/W1989461604","https://openalex.org/W1998432569","https://openalex.org/W2020678484","https://openalex.org/W2020701688","https://openalex.org/W2023850841","https://openalex.org/W2035731483","https://openalex.org/W2039704550","https://openalex.org/W2047611016","https://openalex.org/W2054253814","https://openalex.org/W2056068425","https://openalex.org/W2066674793","https://openalex.org/W2074525536","https://openalex.org/W2170601956","https://openalex.org/W2183985159","https://openalex.org/W2184694295","https://openalex.org/W2263003762","https://openalex.org/W2599801457","https://openalex.org/W2606981611","https://openalex.org/W2758199728","https://openalex.org/W2778628346","https://openalex.org/W2788688494","https://openalex.org/W2790672246","https://openalex.org/W2790794773","https://openalex.org/W2898424795","https://openalex.org/W2903350476","https://openalex.org/W2912078797","https://openalex.org/W2945336367","https://openalex.org/W2952998155","https://openalex.org/W2969088060","https://openalex.org/W3044476801","https://openalex.org/W3082648185","https://openalex.org/W3097777064","https://openalex.org/W3110830766","https://openalex.org/W3111317163","https://openalex.org/W3138712001","https://openalex.org/W3205724362","https://openalex.org/W3216800458","https://openalex.org/W4211104845","https://openalex.org/W4226318573","https://openalex.org/W4281848048","https://openalex.org/W4384398258","https://openalex.org/W4393935425","https://openalex.org/W4401322672","https://openalex.org/W4402126141","https://openalex.org/W4403261875","https://openalex.org/W4408124212","https://openalex.org/W4409519918","https://openalex.org/W4411123702","https://openalex.org/W4415603394","https://openalex.org/W4417495600","https://openalex.org/W7117673581","https://openalex.org/W7157196084"],"related_works":["https://openalex.org/W7153174724","https://openalex.org/W2159610773","https://openalex.org/W7098022579","https://openalex.org/W2054253814","https://openalex.org/W2044647958","https://openalex.org/W2045660460","https://openalex.org/W1517724727","https://openalex.org/W4320922944","https://openalex.org/W2389071987","https://openalex.org/W4362585412"],"abstract_inverted_index":{"Introduction.":[0],"Paclitaxel":[1,80,130,161],"is":[2,52,81,100],"a":[3,13,132,142,222],"plant-derived":[4],"antineoplastic":[5],"agent":[6],"with":[7],"high":[8,33,204],"potential":[9],"in":[10,39,92,211,264,270,282,315,330],"the":[11,20,40,63,70,76,84,90,110,168,187,215,236,247,265,276,285,297,309,348],"treatment":[12,91,266],"wide":[14],"range":[15],"of":[16,23,42,61,66,72,83,98,112,183,206,217,230,238,243,253,258,267,278,287,299,350,354],"malignant":[17,325],"neoplasms.":[18],"However,":[19],"unique":[21],"properties":[22,229],"paclitaxel":[24,67,207,218,259,317,328],"\u2013":[25,35],"low":[26,175,178,196,199],"aqueous":[27],"solubility,":[28,200],"poor":[29,201],"oral":[30],"bioavailability,":[31,202],"and":[32,116,126,145,173,177,193,203,227,249,332,336],"toxicity":[34,205],"create":[36],"considerable":[37],"challenges":[38,210,314],"development":[41,192,286,349],"stable":[43],"formulations,":[44],"substantially":[45],"limiting":[46],"its":[47,103,158,305],"clinical":[48,283],"application.":[49],"Therefore,":[50],"there":[51],"an":[53],"active":[54],"ongoing":[55],"search":[56],"for":[57,89,190,246,323],"novel":[58,333],"technologies":[59],"capable":[60],"enhancing":[62,300],"therapeutic":[64],"efficacy":[65,248],"while":[68,303],"reducing":[69,304],"impact":[71],"toxic":[73,306],"effects":[74,307],"on":[75,102,107,225,308,347],"human":[77,310],"body.":[78,311],"Text.":[79],"one":[82],"most":[85,188],"widely":[86],"used":[87,263,281],"drugs":[88,255],"modern":[93],"oncology.":[94],"Its":[95],"antitumor":[96,254],"mechanism":[97],"action":[99],"based":[101],"ability":[104],"to":[105,123,163,167,291],"act":[106],"tubulin,":[108],"stimulating":[109],"assembly":[111],"microtubules,":[113],"stabilizing":[114],"them,":[115],"thus":[117],"preventing":[118],"their":[119],"dissociation,":[120],"which":[121],"leads":[122],"mitotic":[124],"arrest":[125],"subsequent":[127],"cell":[128],"death.":[129],"possesses":[131],"complex":[133],"structure":[134],"comprising":[135],"various":[136],"functional":[137],"groups,":[138],"including":[139],"ester":[140],"linkages,":[141],"taxane":[143],"ring,":[144],"aromatic":[146],"moieties.":[147],"These":[148],"molecular":[149],"elements":[150],"determine":[151],"paclitaxel's":[152,301],"anticancer":[153],"activity":[154],"as":[155,157],"well":[156],"physicochemical":[159],"properties.":[160],"belongs":[162],"Class":[164],"IV":[165],"according":[166],"Biopharmaceutics":[169],"Classification":[170],"System":[171],"(BCS)":[172],"has":[174],"solubility":[176],"intestinal":[179],"permeability.":[180],"Drug":[181],"substances":[182],"this":[184,292],"class":[185],"are":[186,319,329,338],"challenging":[189],"formulation":[191],"exhibit":[194],"extremely":[195],"bioavailability.":[197],"The":[198,313],"pose":[208],"significant":[209,223],"pharmaceutical":[212],"development.":[213],"Furthermore,":[214],"polymorphism":[216],"can":[219,241],"also":[220,257],"have":[221],"influence":[224],"stability":[226],"biopharmaceutical":[228],"finished":[231],"dosage":[232,352],"forms.":[233],"For":[234],"example,":[235],"choice":[237],"polymorphic":[239],"form":[240],"be":[242],"fundamental":[244],"importance":[245],"safety":[250],"not":[251],"only":[252],"but":[256],"coated":[260],"medical":[261],"devices":[262],"cardiovascular":[268],"diseases,":[269],"particular":[271],"restenosis":[272],"after":[273],"angioplasty.":[274],"Despite":[275],"availability":[277],"formulations":[279,318],"successfully":[280],"practice,":[284],"new":[288,351],"ones":[289],"continues":[290],"day.":[293],"Nowadays,":[294],"researchers":[295],"face":[296],"task":[298],"bioavailability":[302],"Conclusion.":[312],"developing":[316],"multifaceted.":[320],"New":[321],"strategies":[322],"treating":[324],"tumors":[326],"using":[327],"place,":[331],"drug":[334],"compositions":[335],"combinations":[337],"under":[339],"investigation.":[340],"This":[341],"work":[342],"reviews":[343],"contemporary":[344],"studies":[345],"focused":[346],"forms":[353],"paclitaxel.":[355]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-08-10T00:00:00"}